Developer docs
API playgroundTry for free, no card

Search company profiles

Psygen Labs

Full company profile

uuid00032uo

Namestring
Psygen Labs
Legal namestring
Psygen Industries Ltd.
Websiteurl
psygen.ca
Company typeenum
Private
Founded yearint
2019
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCalgary, Canada
HQ citystring
Calgary
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pharmaceutical API manufacturing, psychedelic drug development, contract manufacturing services, GMP API production, CMC pharmaceutical services
Industry4 codes
PRIMARYHLAGABAA
Small-Molecule API & Intermediates CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAIALAD
CMC & Pharmaceutical Development (Formulation/Process/Analytical Development)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
NAICS code2 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical CDMO / Psychedelic API Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Manufacturing Services
TypeProfessional Services
Description

B2B contract development and manufacturing services for pharmaceutical companies and research organizations requiring early-stage development and clinical manufacturing of psychedelic and neuroplastogen APIs. Revenue is generated through project-based contracts with pharmaceutical clients.

Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Psygen Labs is a Canadian Contract Development and Manufacturing Organization (CDMO) that manufactures psychedelic and neuroplastogen Active Pharmaceutical Ingredients (APIs) such as LSD, DMT, 5-MeO-DMT, Ibogaine, Psilocybin, and MDMA for clinical research and pharmaceutical development. The company offers integrated CMC (Chemistry, Manufacturing and Controls) services spanning Process Research & Development, Phase I–III API Production, and Technology Transfer under GMP-aligned conditions.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Psygen is a Contract Development and Manufacturing Organization (CDMO) operating under 'The Psychedelic CDMO™' brand. It is the only company solely focused on manufacturing psychedelic and neuroplastogen APIs. The company offers an integrated CMC (Chemistry, Manufacturing, and Controls) services platform comprising Process R&D, Phase I-III API Production, and Technology Transfer. Psygen manufactures six primary psychedelic APIs: LSD, DMT, 5-MeO-DMT, Ibogaine, Psilocybin, and MDMA, serving clinical and scientific research clients globally.

Product and service5 records
1Psychedelic Active Pharmaceutical Ingredients (APIs)
CategoryActive Pharmaceutical Ingredients
Description

Pharmaceutical-grade active ingredients including LSD, DMT, 5-MeO-DMT, Ibogaine, Psilocybin, and MDMA, produced under GMP-aligned conditions for use by pharmaceutical companies and clinical researchers developing psychedelic-based therapeutics.

2CMC Services (Chemistry, Manufacturing and Controls)
CategoryContract Development and Manufacturing Services
Description

Integrated contract development offering comprising Process Research & Development, Phase I–III API Production, and Technology Transfer, designed for pharmaceutical companies and clinical-stage drug developers needing support across the psychedelic API development lifecycle.

3Process Research & Development
CategoryContract Development Services
Description

Contracted laboratory research to develop and optimize synthetic routes and processes for psychedelic APIs prior to scale-up manufacturing, targeted at pharmaceutical clients progressing candidates toward clinical trials.

4Phase I–III API Production
CategoryContract Manufacturing Services
Description

Small- to mid-scale production of psychedelic APIs to supply Phase I, II, and III clinical trials, available to pharmaceutical companies and research organizations advancing psychedelic-based therapeutics.

5Technology Transfer Services
CategoryContract Development Services
Description

Transfer of manufacturing processes and documentation to clients or their designated manufacturers to enable scale-up and commercial production, supporting pharmaceutical partners moving from clinical to commercial supply.

Partnership1 partner
Strategic tierSupportingTypeOthers
Description

Psygen Labs participates in Canada's Special Access Program by donating psychedelic medications to physicians. This is not a formal partnership but rather a regulatory participation program allowing access to restricted medications for medical purposes.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Patheon, now part of Thermo Fisher's pharma services segment, is a top-tier global CDMO offering API and drug product development/manufacturing. Comparable to Psygen as a contract API manufacturer for pharmaceutical clients, but at vastly greater scale and across many therapeutic areas.

TypeBroad incumbent
Description

Lonza is a leading global CDMO for small molecules, biologics, and cell/gene therapies. Comparable to Psygen in providing GMP API and process development services, but operates at much larger scale and across multiple modalities.

TypeBroad incumbent
Description

Catalent is one of the largest global CDMOs providing formulation, clinical and commercial manufacturing for oral, sterile, and biologic dosage forms. Comparable to Psygen in providing GMP contract manufacturing, but operates across a far broader therapeutic and dosage-form portfolio.

TypeDirect peer
Description

Avid Bioservices is a mid-sized CDMO focused on biologics process development, GMP manufacturing, and analytical services. Comparable to Psygen as a mid-sized CDMO with concentrated focus on a specialized manufacturing segment and project-based B2B client engagements.

TypeDirect peer
Description

Halo Pharma, now part of Bora Pharmaceuticals, is a CDMO offering oral solid dose and specialty drug product development and manufacturing. Comparable to Psygen as a smaller specialty CDMO serving mid-sized pharma with project-based contract manufacturing engagements.

TypeBroad incumbent
Description

WuXi STA is one of the largest global API CDMOs, offering process R&D and GMP manufacturing of small-molecule APIs. Comparable to Psygen in providing small-molecule API CDMO services for clinical-stage programs, but at dramatically larger scale and broader scope.

TypeDirect peer
Description

Alcami is a U.S.-based specialty CDMO offering API development, analytical services, and drug product manufacturing for small and mid-sized pharma clients. Comparable to Psygen as a focused CDMO serving niche/specialty pharmaceutical pipelines with custom development and manufacturing.

8Contract Pharmaceuticals Limited (CPL)
TypeDirect peer
Description

CPL is a specialty CDMO focused on liquid and semi-solid pharmaceutical development and manufacturing. Comparable to Psygen as a focused, mid-sized CDMO providing specialized contract manufacturing services for niche therapeutic and clinical-stage programs.

9Pyramid Laboratories
TypeDirect peer
Description

Pyramid Laboratories is a smaller specialty CDMO offering aseptic fill-finish, analytical, and small-batch GMP manufacturing. Comparable to Psygen as a boutique CDMO serving niche/specialty pharmaceutical pipelines with focused manufacturing capabilities.

TypeBroad incumbent
Description

PCI Pharma Services is a global CDMO providing clinical and commercial supply, packaging, and manufacturing services. Comparable to Psygen as a contract service provider to pharma clients across clinical phases, but with broader packaging and commercial supply capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Psygen Labs

Pharmaceutical CDMO / Psychedelic API Manufacturingpsygen.ca

Psygen Labs firmographics

Firmographics
Name
Psygen Labs
Legal name
Psygen Industries Ltd.
Website
https://psygen.ca
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Psygen Labs industry classification

Industry
Product category
Pharmaceutical CDMO / Psychedelic API Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGABAA
Small-Molecule API & Intermediates CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAIALAD
CMC & Pharmaceutical Development (Formulation/Process/Analytical Development)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development

Keywords

  • Pharmaceutical API manufacturing
  • Psychedelic drug development
  • Contract manufacturing services
  • GMP API production
  • CMC pharmaceutical services

Where Psygen Labs is headquartered

Location

Headquarters

HQ city
Calgary
HQ country
Canada
HQ region
North America

Markets served

Psygen Labs business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Contract Manufacturing Services: B2B contract development and manufacturing services for pharmaceutical companies and research organizations requiring early-stage development and clinical manufacturing of psychedelic and neuroplastogen APIs. Revenue is generated through project-based contracts with pharmaceutical clients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Psygen Labs product offering

Product offering

Core offering

Psygen Labs is a Canadian Contract Development and Manufacturing Organization (CDMO) that manufactures psychedelic and neuroplastogen Active Pharmaceutical Ingredients (APIs) such as LSD, DMT, 5-MeO-DMT, Ibogaine, Psilocybin, and MDMA for clinical research and pharmaceutical development. The company offers integrated CMC (Chemistry, Manufacturing and Controls) services spanning Process Research & Development, Phase I–III API Production, and Technology Transfer under GMP-aligned conditions.

Product overview

Psygen is a Contract Development and Manufacturing Organization (CDMO) operating under 'The Psychedelic CDMO™' brand. It is the only company solely focused on manufacturing psychedelic and neuroplastogen APIs. The company offers an integrated CMC (Chemistry, Manufacturing, and Controls) services platform comprising Process R&D, Phase I-III API Production, and Technology Transfer. Psygen manufactures six primary psychedelic APIs: LSD, DMT, 5-MeO-DMT, Ibogaine, Psilocybin, and MDMA, serving clinical and scientific research clients globally.

Differentiator

Problem solved

Functional benefit

Products and services

  • Psychedelic Active Pharmaceutical Ingredients (APIs) Pharmaceutical-grade active ingredients including LSD, DMT, 5-MeO-DMT, Ibogaine, Psilocybin, and MDMA, produced under GMP-aligned conditions for use by pharmaceutical companies and clinical researchers developing psychedelic-based therapeutics.
  • CMC Services (Chemistry, Manufacturing and Controls) Integrated contract development offering comprising Process Research & Development, Phase I–III API Production, and Technology Transfer, designed for pharmaceutical companies and clinical-stage drug developers needing support across the psychedelic API development lifecycle.
  • Process Research & Development Contracted laboratory research to develop and optimize synthetic routes and processes for psychedelic APIs prior to scale-up manufacturing, targeted at pharmaceutical clients progressing candidates toward clinical trials.
  • Phase I–III API Production Small- to mid-scale production of psychedelic APIs to supply Phase I, II, and III clinical trials, available to pharmaceutical companies and research organizations advancing psychedelic-based therapeutics.
  • Technology Transfer Services Transfer of manufacturing processes and documentation to clients or their designated manufacturers to enable scale-up and commercial production, supporting pharmaceutical partners moving from clinical to commercial supply.

Companies that use Psygen Labs

Customer profile

Segments1 record

Ideal customer profiles2 records

Psygen Labs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Psygen Labs partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Canadian Healthcare System (via Special Access Program)supportingOthersPsygen Labs participates in Canada's Special Access Program by donating psychedelic medications to physicians. This is not a formal partnership but rather a regulatory participation program allowing access to restricted medications for medical purposes.

Recent moves7 records

Expansion highlights4 records

Psygen Labs competitors and assessment

Company assessment

Broad incumbents

  • Patheon (Thermo Fisher Scientific): Patheon, now part of Thermo Fisher's pharma services segment, is a top-tier global CDMO offering API and drug product development/manufacturing. Comparable to Psygen as a contract API manufacturer for pharmaceutical clients, but at vastly greater scale and across many therapeutic areas.
  • Lonza Group: Lonza is a leading global CDMO for small molecules, biologics, and cell/gene therapies. Comparable to Psygen in providing GMP API and process development services, but operates at much larger scale and across multiple modalities.
  • Catalent: Catalent is one of the largest global CDMOs providing formulation, clinical and commercial manufacturing for oral, sterile, and biologic dosage forms. Comparable to Psygen in providing GMP contract manufacturing, but operates across a far broader therapeutic and dosage-form portfolio.
  • WuXi AppTec / WuXi STA: WuXi STA is one of the largest global API CDMOs, offering process R&D and GMP manufacturing of small-molecule APIs. Comparable to Psygen in providing small-molecule API CDMO services for clinical-stage programs, but at dramatically larger scale and broader scope.
  • PCI Pharma Services: PCI Pharma Services is a global CDMO providing clinical and commercial supply, packaging, and manufacturing services. Comparable to Psygen as a contract service provider to pharma clients across clinical phases, but with broader packaging and commercial supply capabilities.

Direct peers

  • Avid Bioservices: Avid Bioservices is a mid-sized CDMO focused on biologics process development, GMP manufacturing, and analytical services. Comparable to Psygen as a mid-sized CDMO with concentrated focus on a specialized manufacturing segment and project-based B2B client engagements.
  • Halo Pharma (Bora Pharmaceuticals): Halo Pharma, now part of Bora Pharmaceuticals, is a CDMO offering oral solid dose and specialty drug product development and manufacturing. Comparable to Psygen as a smaller specialty CDMO serving mid-sized pharma with project-based contract manufacturing engagements.
  • Alcami Corporation: Alcami is a U.S.-based specialty CDMO offering API development, analytical services, and drug product manufacturing for small and mid-sized pharma clients. Comparable to Psygen as a focused CDMO serving niche/specialty pharmaceutical pipelines with custom development and manufacturing.
  • Contract Pharmaceuticals Limited (CPL): CPL is a specialty CDMO focused on liquid and semi-solid pharmaceutical development and manufacturing. Comparable to Psygen as a focused, mid-sized CDMO providing specialized contract manufacturing services for niche therapeutic and clinical-stage programs.
  • Pyramid Laboratories: Pyramid Laboratories is a smaller specialty CDMO offering aseptic fill-finish, analytical, and small-batch GMP manufacturing. Comparable to Psygen as a boutique CDMO serving niche/specialty pharmaceutical pipelines with focused manufacturing capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Psygen Labs social profiles

Digital presence

Psygen Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Psygen Labs leadership team

Management profile

Number of profiles

Profiles8 records

Psygen Labs funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Psygen Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Psygen Labs

What does Psygen Labs do?

Psygen Labs is a Canadian Contract Development and Manufacturing Organization (CDMO) that manufactures psychedelic and neuroplastogen Active Pharmaceutical Ingredients (APIs) such as LSD, DMT, 5-MeO-DMT, Ibogaine, Psilocybin, and MDMA for clinical research and pharmaceutical development. The company offers integrated CMC (Chemistry, Manufacturing and Controls) services spanning Process Research & Development, Phase I–III API Production, and Technology Transfer under GMP-aligned conditions.

Is Psygen Labs a public or private company?

Psygen Labs is a private company. It is classified as venture growth investor backed and is currently operating.

When was Psygen Labs founded?

Psygen Labs was founded in 2019. It employs 11 to 50 people.

Where is Psygen Labs based?

Psygen Labs is headquartered in Calgary, Canada, in the North America region.

How does Psygen Labs make money?

One revenue line is on record: contract Manufacturing Services.

Who are Psygen Labs's main competitors?

Broad incumbents on record are Patheon (Thermo Fisher Scientific), Lonza Group, Catalent, WuXi AppTec / WuXi STA and PCI Pharma Services. Direct peers are Avid Bioservices, Halo Pharma (Bora Pharmaceuticals), Alcami Corporation, Contract Pharmaceuticals Limited (CPL) and Pyramid Laboratories.

Does Psygen Labs have an API?

No public API is recorded for Psygen Labs.

What industry is Psygen Labs in?

Psygen Labs's product category is Pharmaceutical CDMO / Psychedelic API Manufacturing. Its primary akta.pro industry code is HLAGABAA, Small-Molecule API & Intermediates CDMO, with a secondary code of HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 3254 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals